Close

RTapp™ a state-of-the-art, cloud-based  platform for improving radiation treatment of cancer. RTapp is pending FDA clearance.

The company’s proprietary, state of the art platform will save significant time through automation.  RTapp will provide Radiation Oncology Teams with the technology to automatically visualize daily changes in anatomy throughout the entire course of treatment, identify more plans at risk, and predict when treatment plans will exceed constraints.